Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock (Q45023377)

8 December 2017

Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock (English)

1 reference

8 December 2017

0 references

0 references

1 reference

1 reference

Peter C Minneci

1

1 reference

8 December 2017

Katherine J Deans

2

1 reference

8 December 2017

Steven M Banks

3

1 reference

8 December 2017

Renee Costello

4

1 reference

8 December 2017

Gyorgy Csako

5

1 reference

8 December 2017

Peter Q Eichacker

6

1 reference

8 December 2017

Robert L Danner

7

1 reference

8 December 2017

Charles Natanson

8

1 reference

8 December 2017

Steven B Solomon

9

1 reference

8 December 2017

19 August 2004

1 reference

American Journal of Physiology Heart and Circulatory Physiology

8 December 2017

1 reference

8 December 2017

287

1 reference

8 December 2017

6

1 reference

8 December 2017

H2545-54

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

8 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Epidemiology of sepsis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Hemodynamic support in fluid-refractory pediatric septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Physiology of vasopressin relevant to management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Pharmacologic issues in the management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Use of vasopressor agents in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Effects of norepinephrine on right ventricular function in septic shock patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Epinephrine impairs splanchnic perfusion in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Profound but reversible myocardial depression in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Is it time to reposition vasopressors and inotropes in sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Circulating vasopressin levels in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Sympathetic blockade in a canine model of gram-negative bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Heart failure in pediatric septic shock: utilizing inotropic support

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00450.2004

10.1152/AJPHEART.00450.2004

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference